EP2386302A1 — A controlled release pharmaceutical dosage form of trimetazidine and processes for the preparation thereof
Assigned to Ranbaxy Laboratories Ltd · Expires 2011-11-16 · 15y expired
What this patent protects
A controlled release pharmaceutical dosage forms of trimetazidine and the process of preparation thereof, suitable for once-daily dosing is disclosed. The controlled release pharmaceutical dosage form of trimetazidine comprises trimetazidine or its pharmaceutically acceptable sal…
USPTO Abstract
A controlled release pharmaceutical dosage forms of trimetazidine and the process of preparation thereof, suitable for once-daily dosing is disclosed. The controlled release pharmaceutical dosage form of trimetazidine comprises trimetazidine or its pharmaceutically acceptable salts; one or more gel-forming materials; and one or more gas generating materials.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.